LeoNex

AI Companion

AI Health Assistant

LeoNex AI

Context-aware · RAG over your protocols

Premium
Hi — I'm your LeoNex AI companion. I have context on your active protocols and a database of 85+ peptide compounds. Ask me about dosing, half-lives, site rotation, or interactions. (Demo: responses are generated locally, not via a live LLM.)

Compound Database

Semaglutide

GLP-1

t½ 165h · 0.25–2.4 mg / week

GLP-1 receptor agonist studied for appetite regulation and glycemic control. Long half-life supports once-weekly dosing.

Tirzepatide

GLP-1

t½ 120h · 2.5–15 mg / week

Dual GIP/GLP-1 receptor agonist investigated for weight management and metabolic markers.

BPC-157

Recovery

t½ 4h · 250–500 mcg / day

Gastric-derived peptide studied for tendon, ligament and gut healing in animal models.

TB-500 (Thymosin β4)

Recovery

t½ 6h · 2–5 mg / week

Synthetic fragment of thymosin beta-4 explored for tissue repair and inflammation modulation.

CJC-1295 / Ipamorelin

GH Secretagogue

t½ 30h · 300 mcg / day before bed

Growth hormone secretagogue combination studied for sleep quality and recovery.

Tesamorelin

GH Secretagogue

t½ 26h · 1–2 mg / day

GHRH analog investigated for visceral fat reduction and metabolic health.

Melanotan II

Cosmetic

t½ 2h · 250–500 mcg / day

Melanocortin agonist studied for pigmentation response. Notable side-effect profile.

GHK-Cu

Anti-aging

t½ 5h · 1–3 mg / day

Copper-binding peptide studied for skin repair, collagen stimulation and wound healing.

MOTS-c

Metabolic

t½ 8h · 5–10 mg / week

Mitochondrial-derived peptide investigated for exercise capacity and metabolic regulation.

Epitalon

Anti-aging

t½ 3h · 5–10 mg / cycle

Pineal peptide studied for telomerase activity and circadian regulation in animal models.

AI Protocol Builder

Answer a few questions and the AI suggests a research stack based on your goals.